Kavalali, E. T., & Monteggia, L. M. (2018). The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects. Neuropsychopharmacology.
Chicago ZitierstilKavalali, Ege T., und Lisa M. Monteggia. "The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects." Neuropsychopharmacology 2018.
MLA ZitierstilKavalali, Ege T., und Lisa M. Monteggia. "The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects." Neuropsychopharmacology 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.